AHR and gastric cancer: Genetic depletion of AhR suppresses viability, proliferation, migration, and invasion of gastric cancer cells, and in vivo administration of the AhR inhibitor, biseugenol, prevents gastric tumor growth, metastasis, and peritoneal dissemination (42).